Literature DB >> 31227396

Operative Time as an Independent and Modifiable Risk Factor for Short-Term Complications After Knee Arthroscopy.

Anirudh K Gowd1, Joseph N Liu2, Daniel D Bohl3, Avinesh Agarwalla4, Brandon C Cabarcas5, Brandon J Manderle3, Grant H Garcia3, Brian Forsythe3, Nikhil N Verma6.   

Abstract

PURPOSE: To determine whether operative time is an independent risk factor for 30-day complications after arthroscopic surgical procedures on the knee.
METHODS: The American College of Surgeons National Surgical Quality Improvement Program database was queried between 2005 and 2016 for all arthroscopic knee procedures including lateral release, loose body removal, synovectomy, chondroplasty, microfracture, and meniscectomy. Cases with concomitant procedures were excluded. Correlations between operative time and adverse events were controlled for variables such as age, sex, body mass index, patient comorbidities, and procedure using a multivariate Poisson regression with robust error variance.
RESULTS: A total of 78,864 procedures met our inclusion and exclusion criteria. The mean age of patients was 51.0 ± 14.3 years; mean operative time, 31.2 ± 18.1 minutes; and mean body mass index, 31.0 ± 7.8. Arthroscopic lateral release (coefficient, 5.8; 95% confidence interval [CI], 4.8-6.8; P < .001), removal of loose bodies (coefficient, 4.2; 95% CI, 3.2-5.3; P < .001), synovectomy (coefficient, 1.8; 95% CI, 1.2-2.3; P < .001), and microfracture (coefficient, 6.5; 95% CI, 5.8-7.2; P < .001) had significantly greater durations of surgery in comparison with meniscectomy. The overall rate of adverse events was 1.24%. After we adjusted for demographic characteristics and the procedure, a 15-minute increase in operative duration was associated with an increased risk of transfusion (relative risk [RR], 1.5; 95% CI, 1.3-1.8; P < .001), death (RR, 1.6; 95% CI, 1.2-2.1; P = .005), dehiscence (RR, 1.6; 95% CI, 1.2-2.2; P = .002), surgical-site infection (RR, 1.3; 95% CI, 1.2-1.3; P = .001), sepsis (RR, 1.3; 95% CI, 1.2-1.4; P < .001), readmission (RR, 1.1; 95% CI, 1.1-1.2; P < .001), and extended length of stay (RR, 1.4; 95% CI, 1.3-1.4; P < .001).
CONCLUSIONS: Marginal increases in operative time are associated with an increased risk of adverse events such as surgical-site infection, sepsis, extended length of stay, and readmission. Efforts should be made to maximize surgical efficiency. LEVEL OF EVIDENCE: Level IV, retrospective database study.
Copyright © 2019 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31227396     DOI: 10.1016/j.arthro.2019.01.059

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  12 in total

1.  Risk factors for hospital admission in patients undergoing outpatient anterior cruciate ligament reconstruction: A national database study.

Authors:  Cris J Min; Matthew J Partan; Petros Koutsogiannis; Cesar R Iturriaga; Gus Katsigiorgis; Randy M Cohn
Journal:  J Orthop       Date:  2020-09-29

2.  Allograft contamination during suture preparation for anterior cruciate ligament reconstruction: an ex vivo study.

Authors:  Chenliang Wu; Xiuyuan Zhang; Yi Qiao; Jiebo Chen; Wei Su; Junjie Xu; Zipeng Ye; Jia Jiang; Caiqi Xu; Guoming Xie; Jinzhong Zhao; Song Zhao
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-02-23       Impact factor: 4.342

3.  Treatment of Large Cartilage Defects in the Knee by Hydrogel-Based Autologous Chondrocyte Implantation: Two-Year Results of a Prospective, Multicenter, Single-Arm Phase III Trial.

Authors:  P Niemeyer; M Hanus; J Belickas; T László; R Gudas; M Fiodorovas; A Cebatorius; M Pastucha; P Hoza; K Magos; K Izadpanah; L Paša; G Vásárhelyi; K Sisák; M Mohyla; C Farkas; O Kessler; S Kybal; R Spiro; A Köhler; A Kirner; S Trattnig; C Gaissmaier
Journal:  Cartilage       Date:  2022 Jan-Mar       Impact factor: 3.117

4.  Type of bone graft and primary diagnosis were associated with nosocomial surgical site infection after high tibial osteotomy: analysis of a national database.

Authors:  Manabu Kawata; Taisuke Jo; Shuji Taketomi; Hiroshi Inui; Ryota Yamagami; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga; Sakae Tanaka
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-04-01       Impact factor: 4.342

5.  Risk Factors for Septic Arthritis After Anterior Cruciate Ligament Reconstruction: A Nationwide Analysis of 26,014 ACL Reconstructions.

Authors:  Jesper Kraus Schmitz; Viktor Lindgren; Gunnar Edman; Per-Mats Janarv; Magnus Forssblad; Anders Stålman
Journal:  Am J Sports Med       Date:  2021-03-25       Impact factor: 6.202

6.  Rates and Risk Factors of Revision Arthroscopy or Conversion to Total Knee Arthroplasty Within 1 Year Following Isolated Meniscectomy.

Authors:  Avinesh Agarwalla; Anirudh K Gowd; Joseph N Liu; Nirav H Amin; Brian C Werner
Journal:  Arthrosc Sports Med Rehabil       Date:  2020-10-24

7.  A novel and efficient surgical knotting technique for high-tension closures.

Authors:  Yongyun Chang; Degang Yu; Liao Wang; Jingwei Zhang; Mengning Yan; Huiwu Li; Yuanqing Mao; Zanjing Zhai
Journal:  Ann Transl Med       Date:  2021-03

Review 8.  Operative Approaches to Ankle and Hindfoot Arthroscopy.

Authors:  Dominic S Carreira; Steven R Garden; Thomas Ueland
Journal:  Foot Ankle Orthop       Date:  2020-01-14

9.  A novel efficient and precise technique for removing acetabular osteophytes in patients undergoing total hip arthroplasty: the SH-9Hospital acetabular edge file.

Authors:  Yongyun Chang; Keyu Kong; Yiming Zeng; Degang Yu; Jingwei Zhang; Mengning Yan; Yuanqing Mao; Huiwu Li; Zanjing Zhai
Journal:  Ann Transl Med       Date:  2021-09

10.  Bacterial contamination of irrigation fluid and suture material during ACL reconstruction and meniscus surgery : Low infection rate despite increasing contamination over surgery time.

Authors:  Benjamin Bartek; Tobias Winkler; Anja Garbe; Tarek Schelberger; Carsten Perka; Tobias Jung
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-02-10       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.